March 20 Market Closing Report — KOSPI and KOSDAQ Both Close Higher

Today's Market in One Line

KOSPI and KOSDAQ both rise! KOSDAQ surges 1.58%, showcasing small/mid-cap strength

---

Index Trends

KOSPI

• Close: 5,781.20
• Change: +17.98p (+0.31%)
• KOSPI came close to the 5,800 level, maintaining a solid trend. Simultaneous net buying from foreign and institutional investors lifted the index, with large-caps leading a steady advance.

KOSDAQ

• Close: 1,161.52
• Change: +18.04p (+1.58%)
• Recording a gain more than five times KOSPI's, KOSDAQ was today's star performer. Aggressive retail buying drove strong rebounds in biotech and secondary battery small/mid-cap stocks.

---

Key Issues

• Fed Maintains Rate Hold Stance: After the FOMC minutes release the previous day, rate cut expectations revived slightly, restoring global risk appetite.
• AI/Semiconductor Outlook Improvement: News of expanded AI capex from global big tech had a positive impact on domestic semiconductor and component stocks.
• Biotech Clinical Trial Catalyst: A major domestic biotech company announced positive global Phase 3 clinical trial results, serving as a direct catalyst for KOSDAQ's surge.

---

Sector Performance

• Semiconductors: Concentrated foreign net buying, leading stocks up 1-2%
• Biotech: The key sector driving KOSDAQ's surge, with some stocks approaching circuit breaker levels
• Financials: Profit-taking in bank and insurance stocks on rate cut expectations

---

Tomorrow's Outlook

• Whether KOSPI settles above the 5,800 level is the key factor for short-term direction.
• KOSDAQ may see a pause for breath after the short-term surge.
• Profit-taking may emerge ahead of the weekend, requiring attention to late-session volatility.
• The U.S. Leading Economic Index and European PMI data scheduled for release this afternoon could impact overnight futures markets.

---

Investment Disclaimer

This post is market analysis content written solely for informational purposes and does not constitute a buy/sell recommendation for any specific stock or product. All investment decisions should be made under your own judgment and responsibility, and this blog assumes no liability for any investment gains or losses. Thorough research and professional consultation are always recommended before investing.